Search

Bone Disease - Current Knowledge and Future Prospects

Journal: Current Genomics
Volume: 2 Issue: 2 Year: 2001 Page: 91-124
Author(s): Francesca Lazner, Ernst Wolvetang, Daniel Lazner, Paul Hertzog

Glutamate Signalling in Bone.

Journal: Current Pharmaceutical Design
Volume: 7 Issue: 8 Year: 2001 Page: 737-750
Author(s): T. M. Skerry, A. F. Taylor

Osteoprotegerin A Physiological and Pharmacological Inhibitor of Bone Resorption.

Journal: Current Pharmaceutical Design
Volume: 7 Issue: 8 Year: 2001 Page: 613-635
Author(s): Paul J. Kostenuik, victoria Shalhoub

EXTraordinary Bones: Functional and Genetic Analysis of the EXT Gene Family

Journal: Current Genomics
Volume: 2 Issue: 2 Year: 2001 Page: 125-140
Author(s): Carol A. Wise

The Importance of Drug Delivery to Optimize the Effects of Bone Morphogenetic Proteins During Periodontal Regeneration

Journal: Current Pharmaceutical Biotechnology
Volume: 2 Issue: 2 Year: 2001 Page: 131-142
Author(s): Gaston N. King

Therapeutic Prospects for Parathyroid Hormone and Parathyroid Hormone Analogs

Journal: Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents
Volume: 1 Issue: 3 Year: 2001 Page: 269-287
Author(s): P. Morley, J.F. Whitfield, G.E. Willick

Transplantation-Based Gene Therapy for Inflammatory Diseases Focus on Glomerulonephritis

Journal: Current Gene Therapy
Volume: 1 Issue: 2 Year: 2001 Page: 227-235
Author(s): T. Yokoo, T. Ohashi

Monoclonal Antibodies in the Treatment of Hematologic Malignancies: Radiation Dosimetry Aspects

Journal: Current Pharmaceutical Biotechnology
Volume: 2 Issue: 4 Year: 2001 Page: 351-356
Author(s): M.G. Stabin, A.B. Brill

Antibody Engineering for Targeted Therapy of Cancer Recombinant Fv-Immunotoxins

Journal: Current Pharmaceutical Biotechnology
Volume: 2 Issue: 1 Year: 2001 Page: 19-46
Author(s): Revital Niv, Cyril J. Cohen, Galit Denkberg, Dina Segal, Yoram Reiter

Journal: Current Pharmaceutical Biotechnology
Volume: 2 Issue: 4 Year: 2001 Page: 341-349
Author(s): C. Krasner, R.M. Joyce